Vir Biotechnology (VIR) Other Non-Current Assets (2018 - 2026)

Vir Biotechnology has reported Other Non-Current Assets for 9 years, with the latest figure at $7.0 million in Q1 2026.

• Quarterly Other Non-Current Assets rose 10.89% year-over-year to $7.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.0 million (up 10.89% YoY) and the FY2025 annual result came in at $24.7 million, up 288.17% from the prior year.
• Other Non-Current Assets slipped to $7.0 million in Q1 2026 per VIR's latest filing, from $24.7 million in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $24.7 million in Q4 2025 and troughed at $6.3 million in Q1 2025.
• A 5-year average of $8.5 million and a median of $6.7 million in 2023 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2023 and 2025: Other Non-Current Assets declined 25.45% in 2023, then soared 288.17% in 2025.
• Over 5 years, Other Non-Current Assets stood at $6.7 million in 2022, then slipped by 3.12% to $6.4 million in 2023, then declined by 1.32% to $6.4 million in 2024, then jumped by 288.17% to $24.7 million in 2025, then plunged by 71.84% to $7.0 million in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $7.0 million, $24.7 million, and $16.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.